Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenib

J Clin Oncol. 2013 Jul 1;31(19):e320-1. doi: 10.1200/JCO.2012.45.8307. Epub 2013 May 28.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Diagnosis, Differential
  • Erythema Nodosum / diagnosis
  • Female
  • Glutamic Acid
  • Humans
  • Indoles / administration & dosage
  • Indoles / adverse effects*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / genetics
  • Middle Aged
  • Molecular Targeted Therapy
  • Panniculitis / chemically induced*
  • Panniculitis / diagnosis*
  • Point Mutation*
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Proto-Oncogene Proteins B-raf / genetics
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / genetics
  • Sulfonamides / administration & dosage
  • Sulfonamides / adverse effects*
  • Valine
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • Glutamic Acid
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Valine